PharmaEssentia News and Activities

PharmaEssentia is a company listed under the stock ticker 6446 (TW).

PharmaEssentia has a direct presence in 3 countries.

PharmaEssentia has 4 subsidiaries including Forus Therapeutics, PharmaEssentia Innovation Research Center and PharmaEssentia Japan.

They are in:

• Biotechnology60%
• Pharmaceuticals40%

Acquisition, funding and merger involving PharmaEssentia.

• PharmaEssentia has acquired Forus Therapeutics (posted on June 18 2026).

View the org chart displaying its 54 main executives

Most searched biographies at PharmaEssentia

• Ko Chung Lin, Chief Executive Officer
• Ching Leou Teng, Chairman of the Board
• Shenyi Li, Director

Create your alert
to follow the executive moves at PharmaEssentia.

PharmaEssentia has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by PharmaEssentia

• PharmaEssentia | News
• PharmaEssentia | News
• PharmaEssentia | News
• PharmaEssentia | News | MPNs
• PharmaEssentia | News | MPNs
• PharmaEssentia | News | MPNs
• PharmaEssentia | News | MPNs
• View more press releases Close

Social media about PharmaEssentia

• PharmaEssentia on Wikipedia, Google News & Yahoo Finance
• PharmaEssentia on LinkedIn, X (Twitter) & YouTube